nAChRα6 Discovery Program(Rapport Therapeutics)

N/A

Report date: 2024/09/23 14:53:27
NME

Base Information

Drug NamenAChRα6 Discovery Program(Rapport Therapeutics)
Drug Alias Namealpha-6 nicotinic acetylcholine receptor modulators (Rapport Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic acetylcholine receptor alpha 6 modulators
TargetsNicotinic acetylcholine receptor alpha 6
Therapy Area/IndicationsChronic Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRapport Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRapport Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsChronic Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A